MS
Schmolke, Mirco
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Ex vivo modeling of lung tissue resident antimicrobial responses | MBio | 2026 | 1 | 0 | |||
| Identification of host cell surface proteins inhibiting furin dependent proteolytic processing of viral glycoproteins | Scientific reports | 2025 | 55 | 22 | |||
| Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy | Antiviral research | 2024 | 159 | 234 | |||
| A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI) | Frontiers in immunology | 2024 | 113 | 205 | |||
| Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3 | Journal of virology | 2024 | 254 | 195 | |||
| Influenza A virus infection alters the resistance profile of gut microbiota to clinically relevant antibiotics | Microbiology spectrum | 2023 | 176 | 173 | |||
| Influenza A virus exploits transferrin receptor recycling to enter host cells | Proceedings of the National Academy of Sciences of the United States of America | 2023 | 374 | 340 | |||
| Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial Cells | Microbiology spectrum | 2023 | 187 | 155 | |||
| Silent neonatal influenza A virus infection primes systemic antimicrobial immunity | Frontiers in immunology | 2023 | 396 | 122 | |||
| A quantitative model for virus uncoating predicts influenza A infectivity | Cell reports | 2023 | 181 | 68 | |||
| Optimizing the live attenuated influenza A vaccine backbone for high-risk patient groups | Journal of virology | 2022 | 244 | 296 | |||
| A single respiratory tract infection early in life reroutes healthy microbiome development and affects adult metabolism in a preclinical animal model | npj biofilms and microbiomes | 2022 | 252 | 152 | |||
| Visualization of respiratory commensal bacteria in context of their natural host environment | Frontiers in Microbiology | 2021 | 283 | 191 | |||
| Influenza A viruses balance ER stress with host protein synthesis shutoff | Proceedings of the National Academy of Sciences | 2021 | 450 | 11 | |||
| Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophages | EMBO Reports | 2020 | 393 | 0 | |||
| Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection | Nature Communications | 2020 | 544 | 226 | |||
| Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization | eLife | 2020 | 461 | 226 | |||
| Ménage à trois: virus, host, and microbiota in experimental infection models | Trends in Microbiology | 2019 | 445 | 628 | |||
| Influenza A Virus Genetic Tools: From Clinical Sample to Molecular Clone | Influenza Virus. Methods in Molecular Biology | 2018 | 472 | 4 | |||
| Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target | Nature Communications | 2018 | 492 | 254 | |||
| Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlan | Frontiers in Immunology | 2018 | 499 | 548 | |||
| H5N1 influenza A virus PB1-F2 relieves HAX-1-mediated restriction of avian virus polymerase PA in human lung cells | Journal of Virology | 2018 | 328 | 247 | |||
| Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis | Microbiome | 2018 | 385 | 162 | |||
| RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus Infection | PLOS pathogens | 2016 | 629 | 349 | |||
| The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA | Journal of virology | 2015 | 703 | 2 | |||
| Human dendritic cell response signatures distinguish 1918, pandemic and seasonal H1N1 influenza viruses | Journal of virology | 2015 | 669 | 3 | |||
| Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein | PLOS pathogens | 2015 | 735 | 291 | |||
| Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency | Science | 2015 | 801 | 2 | |||
| The origin of the PB1 segment of swine influenza A virus subtype H1N2 determines viral pathogenicity in mice | Virus research | 2014 | 555 | 372 | |||
| Avian influenza A H10N8--a virus on the verge? | Lancet | 2014 | 503 | 602 | |||
| A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence | Journal of virology | 2014 | 603 | 432 | |||
| Divergent H7 immunogens offer protection from H7N9 virus challenge | Journal of virology | 2014 | 723 | 0 | |||
| RIG-I detects mRNA of intracellular Salmonella enterica serovar Typhimurium during bacterial infection | MBio | 2014 | 740 | 244 | |||
| Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection | The Journal of biological chemistry | 2014 | 739 | 347 | |||
| 17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha | Viral immunology | 2014 | 596 | 275 | |||
| Highly pathogenic influenza viruses inhibit inflammatory response in monocytes via activation of rar-related orphan receptor RORα | Journal of innate immunity | 2013 | 580 | 0 | |||
| Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility | Nature communications | 2013 | 628 | 339 | |||
| Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction | Journal of virology | 2012 | 518 | 225 | |||
| Host modulators of H1N1 cytopathogenicity | PloS one | 2012 | 585 | 1,387 | |||
| Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export | The Journal of cell biology | 2012 | 550 | 0 | |||
| Cross-presenting CD103+ dendritic cells are protected from influenza virus infection | The Journal of clinical investigation | 2012 | 506 | 0 | |||
| The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein | PLOS pathogens | 2011 | 683 | 323 | |||
| Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species | PLOS pathogens | 2011 | 585 | 428 | |||
| Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor | Nature chemical biology | 2011 | 601 | 297 | |||
| H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response | The Journal of immunology | 2011 | 516 | 0 | |||
| Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein | Journal of virology | 2010 | 563 | 336 | |||
| Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4) | The Journal of biological chemistry | 2010 | 534 | 0 | |||
| NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets | Vaccine | 2010 | 638 | 967 | |||
| PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models | Journal of virology | 2010 | 634 | 319 | |||
| Evasion of innate and adaptive immune responses by influenza A virus | Cellular microbiology | 2010 | 625 | 495 | |||
| Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome | The Journal of immunology | 2009 | 598 | 776 |
